These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28190597)

  • 1. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
    Subramanian S; Tangka FKL; Hoover S; Royalty J; DeGroff A; Joseph D
    Eval Program Plann; 2017 Jun; 62():73-80. PubMed ID: 28190597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.
    Subramanian S; Tangka FKL; Hoover S; Cole-Beebe M; Joseph D; DeGroff A
    Prev Chronic Dis; 2019 Apr; 16():E50. PubMed ID: 31022371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).
    Tangka FKL; Subramanian S; Hoover S; Royalty J; Joseph K; DeGroff A; Joseph D; Chattopadhyay S
    Eval Program Plann; 2017 Jun; 62():67-72. PubMed ID: 27989647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
    Tangka FK; Subramanian S; Beebe MC; Hoover S; Royalty J; Seeff LC
    Cancer; 2013 Aug; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs.
    Hoover S; Subramanian S; Tangka F
    Prev Chronic Dis; 2019 May; 16():E54. PubMed ID: 31050637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC; DeGroff A; Joseph DA; Royalty J; Tangka FK; Nadel MR; Plescia M
    Cancer; 2013 Aug; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK; Lam CL; Wan YF; Fong DY
    BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and programmatic costs of implementing colorectal cancer screening: evaluation of five programs.
    Subramanian S; Tangka FK; Hoover S; Degroff A; Royalty J; Seeff LC
    Eval Program Plann; 2011 May; 34(2):147-53. PubMed ID: 21036399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Rohan EA
    Cancer; 2013 Aug; 119 Suppl 15():2817-9. PubMed ID: 23868475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
    Fisher JA; Fikry C; Troxel AB
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
    Ladabaum U; Mannalithara A; Mitani A; Desai M
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.